Affiliations 

  • 1 Neurovirology Project, Tokyo Metropolitan Institute of Medical Science, 156-8506, Tokyo, Japan
  • 2 Department of Pathology, University of Malaya, 59100, Kuala Lumpur, Malaysia
  • 3 Technical Support Center for Life Science Research, Iwate Medical University, 028-3694, Iwate, Japan
  • 4 Vaccine R&D center, National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan Town, Miaoli County, 35053, Taiwan
  • 5 Molecular NeuroPathobiology Laboratory, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, United Kingdom
Biol Open, 2022 Sep 15;11(9).
PMID: 35929543 DOI: 10.1242/bio.059469

Abstract

Enterovirus 71 (EV71) is one of the causative agents of hand-foot-and-mouth disease, which in some circumstances could lead to severe neurological diseases. Despite of its importance for human health, little is known about the early stages of EV71 infection. EV71 starts uncoating with its receptor, human scavenger receptor B2 (hSCARB2), at low pH. We show that EV71 was not targeted to lysosomes in human rhabdomyosarcoma cells overexpressing hSCARB2 and that the autophagic pathway is not essential for EV71 productive uncoating. Instead, EV71 was efficiently uncoated 30 min after infection in late endosomes (LEs) containing hSCARB2, mannose-6-phosphate receptor (M6PR), RAB9, bis(monoacylglycero)phosphate and lysosomal associated membrane protein 2 (LAMP2). Furthering the notion that mature LEs are crucial for EV71 uncoating, cation-dependent (CD)-M6PR knockdown impairs EV71 infection. Since hSCARB2 interacts with cation-independent (CI)-M6PR through M6P-binding sites and CD-M6PR also harbor a M6P-binding site, CD-M6PR is likely to play important roles in EV71 uncoating in LEs.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.